Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 28, 2006

Ikonisys Obtains Clearance for Prenatal Testing Application

  • Ikonisys’ fastFISH® auto-amniocyte application was cleared for marketing in the U.S. This product allows for the automated identification and enumeration of chromosomes 13, 18, 21, X, and Y in amniotic fluid cells via fluorescence in situ hybridization, or FISH.

    Numerical aberrations of these chromosomes are linked to birth defects, such as down syndrome. The fastFISH auto-amniocyte product is designed to run on the Ikoniscope® robotic digital microscopy platform.

    “We believe that physicians and consumers will appreciate fastFISH® auto-amniocyte’s rapid and reliable functionality,” says Petros Tsipouras, M.D., chairman and CEO.

    “Further, this application provides laboratories with an economical solution to the industry-wide shortage of trained technical personnel,” he adds.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »